• Abiraterone Acetate: Enhancing CYP17 Inhibitor Workflows in

  2026-05-27

  Harnessing Abiraterone acetate as a potent CYP17 inhibitor transforms prostate cancer research by enabling precise androgen pathway modulation in advanced 3D culture models. This guide delivers protocol strategies, troubleshooting insights, and evidence-led innovations for translational and preclinical studies.

• Dual Luciferase Reporter Gene System: Sensitive Gene Regulat

  2026-05-26

  The Dual Luciferase Reporter Gene System enables highly sensitive, normalized quantification of gene expression regulation in mammalian cells. By leveraging firefly and Renilla luciferase substrates, the K1136 kit from APExBIO facilitates robust bioluminescence reporter assays for transcriptional regulation studies. Its direct-addition workflow supports reproducible, high-throughput luciferase detection and accurate normalization.

• Epalrestat: Aldose Reductase Inhibitor for Neuroprotection R

  2026-05-26

  Epalrestat stands out as a high-purity aldose reductase inhibitor, uniquely enabling advanced oxidative stress and neurodegeneration research. Its robust KEAP1/Nrf2 pathway activation profile and translation-ready solubility streamline workflows for Parkinson’s and diabetic complication models.

• HOXC8 Suppresses Pyroptosis in NSCLC by Repressing Caspase-1

  2026-05-25

  This study uncovers the mechanism by which HOXC8 regulates cell death in non-small cell lung carcinoma (NSCLC), demonstrating that HOXC8 represses caspase-1 expression and thereby prevents pyroptosis. These findings clarify the epigenetic control of inflammatory cell death in lung cancer and highlight therapeutic opportunities for targeting pyroptotic pathways.

• Targeting Fructose Metabolism in Cancer: Insights and Tools

  2026-05-25

  The reference study systematically reviews the role of fructose metabolism in cancer malignancy, highlighting how overactivation of the polyol pathway and related transporters contributes to tumor progression. These findings suggest that targeting aldose reductase and other key enzymes may offer new therapeutic avenues for aggressive cancers, and inform method selection in metabolic research.

• tFUS Mitigates Post-Stroke Neuroinflammation via SHP2 Pathwa

  2026-05-24

  This study reveals that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-driven neuroinflammation after ischemic stroke by regulating the Nespas/miR-383-3p/SHP2 signaling axis in microglia. These findings clarify a mechanistic basis for tFUS-mediated neuroprotection and suggest new strategies for targeting SHP2 in neuroinflammatory disease models.

• Prednisone in Research: Applied Workflows and Troubleshootin

  2026-05-23

  Prednisone, a synthetic corticosteroid, empowers immunology and neurodegeneration research through precise cell cycle arrest and apoptosis induction workflows. This article delivers optimized protocols, advanced troubleshooting, and practical integration of metabolomics insights to maximize reproducibility and impact.

• Epalrestat: Benchmark Aldose Reductase Inhibitor for Researc

  2026-05-22

  Epalrestat is a high-purity aldose reductase inhibitor with demonstrated efficacy in polyol pathway inhibition and KEAP1/Nrf2 pathway activation. Its unique profile supports advanced oxidative stress and diabetic neuropathy research. This article details its biological rationale, mechanism, evidence, and protocol parameters for robust scientific application.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-22

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), potentiate the binding of the SARS-CoV-2 spike protein to the AXL receptor, suggesting a new mechanistic link between the renin-angiotensin system and viral entry. These findings provide a refined molecular context for cross-domain research in cardiovascular, renal, and infectious disease settings.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow, Use,

  2026-05-21

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody sets a new standard for sensitive, multiplexed immunodetection in translational research. Its optimized Alexa Fluor 488 conjugation delivers robust signal amplification, reproducibility, and flexibility across Western blot, immunofluorescence, immunohistochemistry, and flow cytometry workflows.

• Improving In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-21

  Schwartz's dissertation introduces a rigorous framework for disentangling proliferative arrest and cell death in in vitro anti-cancer drug testing. By differentiating between relative and fractional viability, the work provides a more nuanced assessment of compound efficacy, with significant implications for optimizing drug discovery workflows.

• 10074-G5 in Cancer Research: Deep Profiling of c-Myc Inhibit

  2026-05-20

  Explore how 10074-G5, a leading c-Myc inhibitor, enables advanced cancer research through direct disruption of oncogenic transcriptional programs. This article delivers a deep, protocol-driven analysis that bridges molecular innovation with practical assay design.

• ALDH1A3-miR-7 Axis Regulates CD44 via TGF-β/Smad3 in Breast

  2026-05-20

  This study uncovers a regulatory axis where ALDH1A3 knockdown leads to upregulation of miR-7 and consequent downregulation of the breast cancer stem cell marker CD44 through the TGFBR2-Smad3 pathway. The mechanistic insights into TGF-β signaling modulation highlight new targets for breast cancer stem cell intervention.

• Quercetin Inhibits Ferroptosis to Mitigate Liver Injury in W

  2026-05-19

  This study demonstrates that quercetin effectively alleviates liver injury in Wilson's disease by directly inhibiting ferroptosis through the ACSL4/LPCAT3/ALOX15 pathway. The findings provide mechanistic insights and support quercetin's expanding role as a research tool in ferroptosis and liver pathology.

• Difloxacin HCl: Bridging DNA Gyrase Inhibition and MDR Rever

  2026-05-19

  This thought-leadership article examines how Difloxacin HCl, a quinolone antimicrobial antibiotic from APExBIO, empowers translational researchers to address both bacterial DNA replication inhibition and multidrug resistance reversal. Integrating mechanistic insights, comparative analysis, and recent advances in cell cycle checkpoint regulation, we offer a strategic roadmap for experimental design and translational impact that surpasses standard product discussions.

8435 records 11/563 page Previous Next First page 上5页 1112131415 下5页 Last page